PRESS RELEASE February 6, 2013

EpiCept Corporation to Present at the 15th BIO CEO & Investor Conference

TARRYTOWN, N.Y.–(BUSINESS WIRE)– Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that Robert W. Cook, Interim President and Chief Executive Officer, will be presenting at the 15th BIO CEO & Investor Conference on Tuesday, February 12, 2013 at 2:30 PM local time at the Waldorf Astoria, Room Park South, in […]

Keep Reading

PRESS RELEASE January 9, 2013

Daniel Teper of Immune Pharmaceuticals to Present at the 6th Annual OneMedForum

TARRYTOWN, N.Y.–(BUSINESS WIRE)– Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that Daniel Teper, Chief Executive Officer of Immune Pharmaceuticals presented at the 6th Annual OneMedForum, on Wednesday, January 9, 2013 at 1:40 PM Pacific time at The Sir Francis Drake hotel in San Francisco, California. Mr. Teper presented a […]

Keep Reading

PRESS RELEASE November 14, 2012

EpiCept Reports Third Quarter 2012 Operating and Financial Results

TARRYTOWN, N.Y.–(BUSINESS WIRE)– Regulatory News : EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) (the Company) today reported a net loss for the three months ended September 30, 2012 of $1.1 million and a net loss for the nine months ended September 30, 2012 of $1.7 million. These compare with net losses for the […]

Keep Reading

PRESS RELEASE November 12, 2012

EpiCept to Report Third Quarter 2012 Operating and Financial Results on November 14, 2012

TARRYTOWN, N.Y.–(BUSINESS WIRE)– Regulatory News : EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it will host a conference call on Wednesday, November 14, 2012 at 9:00 a.m. Eastern time to discuss recent events and the third quarter 2012 operating and financial results. The call will follow the release of these […]

Keep Reading

PRESS RELEASE November 8, 2012

Immune Pharmaceuticals and EpiCept Corporation Agree to Merge

HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y. –(BUSINESS WIRE)– Regulatory News : Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and EpiCept Corporation (“EpiCept”) (NASDAQ OMX Stockholm Exchange and OTCQX: EPCT) today announced that they have entered into a definitive merger agreement. The transaction is anticipated to close during the first quarter of 2013 and is […]

Keep Reading